<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8290">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01980004</url>
  </required_header>
  <id_info>
    <org_study_id>13-3010</org_study_id>
    <nct_id>NCT01980004</nct_id>
  </id_info>
  <brief_title>Potassium Citrate Supplementation vs. Dietary Counseling</brief_title>
  <official_title>Does Potassium Citrate Supplementation Reduce Stone Recurrence in Calcium Phosphate Stone Formers With Risk Factors?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the role of potassium citrate supplementation with
      dietary education versus dietary education alone in the reduction of stone risks and events
      in patients with predominantly calcium phosphate kidney stones.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">August 2016</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Change in 24-hour urine parameters</measure>
    <time_frame>4-6 weeks from baseline</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Kidney Stone</condition>
  <arm_group>
    <arm_group_label>Dietary Education</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this treatment arm will undergo dietary counseling for the prevention of kidney stone formation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Potassium Citrate and Dietary Education</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this treatment arm will undergo potassium citrate supplementation and dietary counseling for the prevention of kidney stone formation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Potassium Citrate Supplementation</intervention_name>
    <description>20 mEq taken twice daily</description>
    <arm_group_label>Potassium Citrate and Dietary Education</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dietary Education</intervention_name>
    <description>Dietary counseling will include both a verbal discussion in the clinic regarding increased fluid intake, a moderate calcium rich diet and lemonade therapy as well as receiving a written handout on these topics.</description>
    <arm_group_label>Dietary Education</arm_group_label>
    <arm_group_label>Potassium Citrate and Dietary Education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients ≥ 18 years old, being seen at UNC Chapel Hill or Vanderbilt Urology Clinics

          2. Documented stone analysis with ≥ 50% calcium phosphate (hydroxyapatite and/or
             brushite) composition

          3. 24 hour urine citrate (≤ 500) on initial evaluation of at least one 24-hour urine
             study

          4. 24 hour urine pH ≥ 6.0 on initial evaluation of at least one 24-hour urine study

        Exclusion Criteria:

          1. Documented stone analysis with any calcium carbonate or magnesium ammonium phosphate
             composition

          2. Systemic cause for stone disease (primary hyperparathyroidism, complete distal renal
             tubular acidosis, systemic acidosis, active urinary tract infection)

          3. 24 hour urine calcium/kg (&gt; 4) or 24 hour urine calcium/Cr (&gt;140) on initial
             evaluation of at least one 24-hour urine study

          4. Concurrent medication therapy (potassium citrate, sodium citrate, sodium bicarbonate,
             diuretic, angiotensin-converting enzyme inhibitor, angiotensin II receptor
             antagonist, topiramate, acetazolamide)

          5. Renal insufficiency (GFR ≤ 60)

          6. Elevated serum potassium level (≥ 4.5) or hyperkalemia

          7. Low serum bicarbonate level (&lt; 24)

          8. High serum calcium level (&gt;10)

          9. Pregnancy

         10. Inability to obtain informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Davis J Viprakasit, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina, Chapel Hill</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marisa J DeBurkarte, BA</last_name>
    <phone>919-966-7108</phone>
    <email>made@med.unc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>North Carolina Memorial Hospital</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marisa DeBurkarte</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 5, 2014</lastchanged_date>
  <firstreceived_date>November 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Calculi</mesh_term>
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Citric Acid</mesh_term>
    <mesh_term>Potassium Citrate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
